midazolam and fk1706

midazolam has been researched along with fk1706 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hori, K; Ishibashi, K; Kamimura, H; Kowalski, D; Lee, J; Minematsu, T; Moy, S; Usui, T; Zha, J1

Trials

1 trial(s) available for midazolam and fk1706

ArticleYear
Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22.3.1
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:2

    Topics: Adolescent; Adult; Computer Simulation; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunophilins; Ligands; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Tacrolimus; Time Factors; Young Adult

2010